Current Report · Items 5.02 · 8-K

Insulet Corporation

PODDNASDAQEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Filed Sep 10, 2026Accepted Sep 10, 2026, 4:02 PM EDTCIK 1145197Accession 0001145197-26-000175

Company context

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, visit insulet.com or omnipod.com.

Current securities

PODDNASDAQ · EQUITY · Current

Recent company filings

Disclosure sections

Items 5.02

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 3, 2026, Timothy J. Scannell, a member of the Board of Directors (the "Board") of Insulet Corporation (the "Company"), notified the Company of his decision to step down from the Board for health reasons, effective September 3, 2026. The Board and management extend their sincere appreciation to Mr. Scannell for his leadership, unwavering commitment and invaluable guidance to the Company throughout his 12 years of service on the Board, including 7 years as Chairman of the Board, during which he helped guide the Company through a period of significant growth and advancement. On September 8, 2026, Michael R. Minogue also notified the Company of his decision to step down from the Board to focus on his candidacy for Governor of Massachusetts, effective September 15, 2026. The Board and management are grateful to Mr. Minogue for his leadership, dedication and passion during his 9 years of distinguished service to the Company and the Board. Neither Mr. Scannell nor Mr. Minogue resigned due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

Free Registration